Stockreport

Taysha Gene Therapies Full Year 2023 Earnings: Beats Expectations [Yahoo! Finance]

Taysha Gene Therapies, Inc.  (TSHA) 
PDF Net loss: US$111.6m (loss narrowed by 33% from FY 2022). US$0.96 loss per share (improved from US$3.78 loss in FY 2022). All figures shown in the chart above are fo [Read more]